Attached files

file filename
10-K - 10-K - CERAGENIX PHARMACEUTICALS, INC.a09-36262_210k.htm
EX-31.1 - EX-31.1 - CERAGENIX PHARMACEUTICALS, INC.a09-36262_2ex31d1.htm
EX-31.2 - EX-31.2 - CERAGENIX PHARMACEUTICALS, INC.a09-36262_2ex31d2.htm

Exhibit 32.1

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF
FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350

 

The undersigned, Steven S. Porter and Jeffrey S. Sperber of Ceragenix Pharmaceuticals, Inc. (the “Company”), each hereby certifies that, to his knowledge on the date hereof:

 

(a)          the Form 10-K of the Company for the year ended December 31, 2008 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(b)         the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

By:

/s/ STEVEN S. PORTER

 

 

Steven S. Porter

 

 

Chairman and Chief Executive Officer

 

 

 

 

 

 

 

By:

/s/ JEFFREY S. SPERBER

 

 

Jeffrey S. Sperber

Date: April 14, 2010

 

Chief Financial Officer